Schiff, Gordon D.
Klinger, Elissa
Salazar, Alejandra
Medoff, Jeffrey
Amato, Mary G.
John Orav, E.
Shaykevich, Shimon
Seoane, Enrique V.
Walsh, Lake
Fuller, Theresa E.
Dykes, Patricia C.
Bates, David W.
Haas, Jennifer S.
Article History
Received: 7 February 2018
Revised: 10 July 2018
Accepted: 30 August 2018
First Online: 5 October 2018
Compliance with Ethical Standards
: The research protocol was approved by the PHS Institutional Review Board and registered at ExternalRef removed (NCT NCT02087293).
: The content is solely the responsibility of the authors and does not necessarily represent the official views of AHRQ.
: Dr. Schiff previously received grant compensation to evaluate the Medaware software. Dr. Bates consults for EarlySense, which makes patient safety monitoring systems. He receives cash compensation from CDI (Negev), Ltd., which is a not-for-profit incubator for health IT startups. He receives equity from ValeraHealth which makes software to help patients with chronic diseases. He receives equity from Clew which makes software to support clinical decision-making in intensive care. He receives equity from MDClone which takes clinical data and produces deidentified versions of it. Dr. Schiff’s and Dr. Bates’ financial interests have been reviewed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their institutional policies.The remaining authors declare no potential conflicts of interest.